Chugai Pharmaceutical Co(CHGCF)
$45.88+0.33 (+0.72%)
CHGCF
Chugai Pharmaceutical Co earnings date
$45.88
At close:+0.33 (+0.72%)
Chugai Pharmaceutical Co (CHGCF) Q4 2022 Earnings Report
23 Followers
CHGCF Q4 2022 EPS Results
- Actual EPS
- $0.39
- Consensus EPS
- $0.37
- Beat/Miss
- Beat by +$0.02
- One Year Ago EPS
- $0.38
CHGCF Q4 2022 Revenue Results
- Actual Revenue
- $2.78B
- Expected Revenue
- $2.49B
- Beat/Miss
- Beat by +$289.74M
- YoY Revenue Growth
- +36.07%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 02/02/2023
- Time
- Before Open
- Conference Call
- Thursday, February 2, 2023
CHGCF Upcoming Earnings
Chugai Pharmaceutical Co's next earnings date is estimated for February 4, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
CHGCF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 04, 2027 | 2026 (Q4) | 0.49- | 0.49 | ― | ― |
| Oct 27, 2026 | 2026 (Q3) | 0.490.59 | 0.48 | 21.81% (+0.11) | |
| Jul 24, 2026 | 2026 (Q2) | 0.480.44 | 0.37 | 18.95% (+0.07) | |
| Apr 24, 2026 | 2026 (Q1) | 0.420.44 | 0.37 | 18.68% (+0.07) | |
| Jan 29, 2026 | 2025 (Q4) | 0.470.49 | 0.35 | 40.24% (+0.14) | |
| Oct 24, 2025 | 2025 (Q3) | 0.470.48 | 0.42 | 14.67% (+0.06) | |
| Jul 24, 2025 | 2025 (Q2) | 0.470.37 | 0.43 | -14.93% (-0.06) | |
| Apr 24, 2025 | 2025 (Q1) | 0.320.37 | 0.29 | 30.67% (+0.09) | |
| Jan 30, 2025 | 2024 (Q4) | 0.370.35 | 0.35 | 0.37% (+0.00) | |
| Oct 25, 2024 | 2024 (Q3) | 0.380.42 | 0.3 | 41.15% (+0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

